Cognizant (CTSH) Tops Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq end lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Cognizant Technology Solutions (CTSH) PT Raised to $78 at Needham & Company
August 3, 2017 12:56 PM EDTNeedham & Company raised its price target on Cognizant Technology Solutions (NASDAQ: CTSH) to $78.00 (from $72.00) while maintaining a Buy rating following "solid" Q2 results.
Analyst Mayank Tandon commented, "CTSH posted solid 2Q results, beating consensus on revenue, margins, and earnings. Growth in... More
Cognizant shrugs off healthcare worry, tightens FY revenue view
August 3, 2017 6:17 AM EDTBy Rishika Sadam
(Reuters) - Cognizant Technology Solutions Corp raised the lower end of its 2017 revenue forecast, easing concerns of tighter spending from its healthcare clients amid uncertainty surrounding the U.S. healthcare policy.
The healthcare sector's worry has been taking a toll on IT services providers lately, forcing them to give bleak forecasts.
The Republican quest to scrap Obamacare, a major campaign vow by U.S. President Donald Trump, failed last week, after the Senate failed to dismantle the healthcare law.
Cognizant gets a large chunk of its revenue from financial services and healthcare... More
